Modeling HIV transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy
- 1 May 2007
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 19 (5) , 594-604
Abstract
Understanding sexual behavior and assessing transmission risk among people living with HIV-1 is crucial for effective HIV-1 prevention. We describe sexual behavior among HIV-positive persons initiating highly active antiretroviral therapy (HAART) in Beira, Mozambique. We present a Bernoulli process model (tool available online) to estimate the number of sexual partners who would acquire HIV-1 as a consequence of sexual contact with study participants within the prior three months. Baseline data were collected on 350 HAART-naive individuals 18–70 years of age from October 2004 to February 2005. In the three months prior to initiating HAART, 45% (n = 157) of participants had sexual relationships with 191 partners. Unprotected sex occurred in 70% of partnerships, with evidence suggesting unprotected sex was less likely with partners believed to be HIV-negative. Only 26% of the participants disclosed their serostatus to partners with a negative or unknown serostatus. Women were less likely to report concurrent relationships than were men (21 versus 66%; OR 0.13; 95%CI: 0.06, 0.26). Given baseline behaviors, the model estimated 23.2 infections/1,000 HIV-positive persons per year. The model demonstrated HAART along with syphilis and herpes simplex virus type 2 (HSV-2) treatment combined could reduce HIV-1 transmission by 87%; increasing condom use could reduce HIV-1 transmission by 67%.Keywords
This publication has 54 references indexed in Scilit:
- Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examplesSexually Transmitted Infections, 2006
- Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviourSexually Transmitted Infections, 2006
- Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 TrialPLOS Medicine, 2005
- Determinants of the Impact of Sexually Transmitted Infection Treatment on Prevention of HIV Infection: A Synthesis of Evidence from the Mwanza, Rakai, and Masaka Intervention TrialsThe Journal of Infectious Diseases, 2005
- Potential Effect of HIV Type 1 Antiretroviral and Herpes Simplex Virus Type 2 Antiviral Therapy on Transmission and Acquisition of HIV Type 1 InfectionThe Journal of Infectious Diseases, 2005
- Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2004
- Estimativa de aborto induzido: comparação entre duas metodologiasRevista Panamericana de Salud Pública, 2004
- Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- A moment closure model for sexually transmitted disease transmission through a concurrent partnership networkProceedings Of The Royal Society B-Biological Sciences, 2000
- Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trialsThe Lancet, 2000